We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSCO icon
26
Cisco
CSCO
$450B
$153M 0.73%
2,871,816
-19,421
-0.7% -$945K
DFAX icon
27
Dimensional World ex US Core Equity 2 ETF
DFAX
$11.8B
$139M 0.67%
5,157,093
-20,927
-0.4% -$543K
BKNG icon
28
Booking.com
BKNG
$138B
$137M 0.65%
811,850
-117,375
-13% -$18M
TJX icon
29
TJX Companies
TJX
$170B
$137M 0.65%
1,162,732
+1,822
+0.2% +$209K
CB icon
30
Chubb
CB
$140B
$128M 0.61%
442,669
-2,811
-0.6% -$771K
VIG icon
31
Vanguard Dividend Appreciation ETF
VIG
$111B
$127M 0.61%
639,463
-1,544
-0.2% -$294K
V icon
32
Visa
V
$677B
$125M 0.6%
455,700
-10,716
-2% -$2.9M
MRK icon
33
Merck
MRK
$324B
$125M 0.6%
1,098,241
+415,340
+61% +$49.3M
UNH icon
34
UnitedHealth
UNH
$382B
$122M 0.58%
208,482
+13,332
+7% +$7.54M
AMAT icon
35
Applied Materials
AMAT
$426B
$118M 0.57%
585,739
-10,413
-2% -$2.14M
COST icon
36
Costco
COST
$415B
$116M 0.55%
130,511
-506
-0.4% -$439K
IWM icon
37
iShares Russell 2000 ETF
IWM
$80.9B
$112M 0.54%
508,663
-1,475
-0.3% -$316K
PH icon
38
Parker-Hannifin
PH
$125B
$111M 0.53%
176,146
-3,791
-2% -$2.15M
APH icon
39
Amphenol
APH
$188B
$110M 0.52%
1,682,734
+177,510
+12% +$11.5M
BRK.B icon
40
Berkshire Hathaway Class B
BRK.B
$1.07T
$107M 0.51%
232,868
+1,543
+0.7% +$682K
MCD icon
41
McDonald's
MCD
$188B
$105M 0.5%
343,306
+8,131
+2% +$2.24M
ADBE icon
42
Adobe
ADBE
$89.5B
$103M 0.49%
199,578
+15,756
+9% +$8.64M
VEA icon
43
Vanguard FTSE Developed Markets ETF
VEA
$226B
$102M 0.49%
1,938,504
+9,571
+0.5% +$487K
RSP icon
44
Invesco S&P 500 Equal Weight ETF
RSP
$96.1B
$101M 0.48%
560,958
-37,223
-6% -$6.36M
USRT icon
45
iShares Core US REIT ETF
USRT
$4.74B
$98.4M 0.47%
1,598,115
-120,375
-7% -$7.03M
IVV icon
46
iShares Core S&P 500 ETF
IVV
$876B
$96.8M 0.46%
167,750
-996
-0.6% -$554K
EWJ icon
47
iShares MSCI Japan ETF
EWJ
$21.7B
$96.4M 0.46%
1,346,971
+17,765
+1% +$1.24M
NFLX icon
48
Netflix
NFLX
$292B
$95.2M 0.46%
1,342,860
-10,370
-0.8% -$694K
WMT icon
49
Walmart Inc
WMT
$871B
$94.4M 0.45%
1,168,732
-9,724
-0.8% -$714K
UNP icon
50
Union Pacific
UNP
$183B
$92.8M 0.44%
376,303
+1,844
+0.5% +$447K
1
2
3 4 5

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.